Abstract

The last decade saw a tremendous evolution of nanocarbon-based biosensors. Most often based on SWIR, or NIR-II (1 - 1.7µm) fluorescence, these novel technologies prompted the development of new imaging and spectroscopic instruments. As these nanosensors are moving from basic and preclinical research to medical and veterinary applications, the instrumentation has to be adapted to large animals, including humans. This talk will focus on the challenges and promises of clinical fluorescence spectrometers and imagers for the SWIR window.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.